Europe Prostate Cancer Nuclear Medicine Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (PET and SPECT), PET Product (F-18, C-11, and Ga68-PSMA), and End User (Hospitals, Clinics, and Others)

No. of Pages: 127
Report Code: BMIRE00025725
Category: Life Sciences
Europe Prostate Cancer Nuclear Medicine Market
Free Sample Buy Now

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Europe Prostate Cancer Nuclear Medicine Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Europe Prostate Cancer Nuclear Medicine Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Europe Prostate Cancer Nuclear Medicine Market Regional Analysis

6.2 Europe Prostate Cancer Nuclear Medicine Market Revenue 2020-2028 (US$ Million)
6.3 Europe Prostate Cancer Nuclear Medicine Market Forecast Analysis

7. Europe Prostate Cancer Nuclear Medicine Market Analysis – by Type

7.1 PET
  • 7.1.1 Overview
  • 7.1.2 PET: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 SPECT
  • 7.2.1 Overview
  • 7.2.2 SPECT: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Prostate Cancer Nuclear Medicine Market Analysis – by PET Product

8.1 F-18
  • 8.1.1 Overview
  • 8.1.2 F-18: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 C-11
  • 8.2.1 Overview
  • 8.2.2 C-11: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Ga68-PSMA
  • 8.3.1 Overview
  • 8.3.2 Ga68-PSMA: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Prostate Cancer Nuclear Medicine Market Analysis – by End User

9.1 Hospitals
  • 9.1.1 Overview
  • 9.1.2 Hospitals: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Clinics
  • 9.2.1 Overview
  • 9.2.2 Clinics: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Prostate Cancer Nuclear Medicine Market – Europe Analysis

10.1 Overview

10.2 Europe
  • 10.2.1 Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.2.1.1 Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast Analysis – by Country
  • 10.2.1.1 UK: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.1.1 UK: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.1.2 UK: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.1.3 UK: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.2.1.2 Germany: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.2.1 Germany: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.2.2 Germany: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.2.3 Germany: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.2.1.3 France: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.3.1 France: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.3.2 France: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.3.3 France: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.2.1.4 Russia: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.4.1 Russia: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.4.2 Russia: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.4.3 Russia: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.2.1.5 Italy: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.5.1 Italy: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.5.2 Italy: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.5.3 Italy: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User
  • 10.2.1.6 Rest of Europe: Europe Prostate Cancer Nuclear Medicine Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.2.1.6.1 Rest of Europe: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by Type
    • 10.2.1.6.2 Rest of Europe: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by PET Product
    • 10.2.1.6.3 Rest of Europe: Europe Prostate Cancer Nuclear Medicine Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments

13. Company Profiles

13.1 Blue Earth Diagnostics Limited
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 ImaginAb
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Curium
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Jubilant Radiopharma
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 ABX advanced biochemical compounds GmbH
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Telix Pharmaceuticals Ltd
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Novartis AG
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Theragnostics
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Lantheus Medical Imaging, Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights
14.2 List of Abbreviations

The List of Companies - Europe Prostate Cancer Nuclear Medicine Market

  • Blue Earth Diagnostics Limited
  • ImaginAb
  • Curium
  • Jubilant Radiopharma
  • ABX advanced biochemical compounds GmbH
  • Telix Pharmaceuticals Ltd
  • Novartis AG
  • Theragnostics
  • Lantheus Medical Imaging, Inc.

    • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)